Skip to main content
. Author manuscript; available in PMC: 2018 Oct 16.
Published in final edited form as: Clin Infect Dis. 2017 Oct 16;65(9):1437–1443. doi: 10.1093/cid/cix561

Table 2.

Additional drug resistance of M. tuberculosis isolates from children with lab-confirmed MDR TB in the United States, 1993–2014 (N=82)

Drug category Tested Resistant
N n %
Other first-line drugs 82 66 81
  Ethambutol 81 47 58
  Pyrazinamide 70 36 51
  Streptomycin 80 56 70
Second-line drugs 73 24 33
  Any second-line injectable 68 10 15
  Any fluoroquinolone 57 5 9
  Extensive drug resistancea 54 3 6
  Other second-line drugsb 70 15 21

MDR TB = multidrug-resistant tuberculosis; M. tuberculosis resistant to isoniazid and rifampicin

a

Resistance to a fluoroquinolone and ≥ 1 second-line injectable

b

cycloserine, ethionamide, p-aminosalicylic acid